Watch 3:07
News Wrap: Iran says ‘no prospect’ of nuclear negotiations with U.S.
In our news wrap Tuesday, a $19 billion disaster aid bill that would have brought much-needed assistance to storm-ravaged areas has stalled for a second time in the House. Republican Rep. Thomas Massie of Kentucky objected to the measure over…
Watch 6:14
How federal case against drug distributor could change opioid fight
Amid the ongoing opioid epidemic, drug manufacturers, doctors and pharmacists have all come under fire. But it's a drug distributor, a company called RDC, at the center of a new federal criminal case that equates its business operations with illegal…
Schumer announces fentanyl sanctions bill before China talks
The Senate’s top Democrat is introducing legislation to “hold China accountable” and sanction laboratories and other traffickers who export fentanyl to the United States.
Opinion: ‘Passive’ fentanyl exposure: more myth than reality
Reports that merely being in a room with fentanyl, a powerful opioid, or its analogues can poison you don't match the action and effects of these drugs.
The Department of Health and Human Services asserted in a letter to the Drug Enforcement Administration that two chemicals in kratom should be classified as Schedule I substances, meaning that the chemicals have “a high potential for abuse” and that…
Growing evidence suggests that women should receive continuous medical attention during what is now called the “fourth trimester” — a period lasting at least a year after childbirth.
Calls to U.S. poison control centers about an unapproved antidepressant that has opioid-like effects have climbed dramatically since 2015, according to a new analysis published by the Centers for Disease Control and Prevention.
WASHINGTON — The White House launched a series of new advertisements Thursday aimed at warning young people about the dangers of opioids, taking another step in the effort to turn the tide against the deadly epidemic.
An analysis of more than five years of Medicare Part D and Medicaid prescription data found that after states legalized weed, the number of opioid prescriptions and the daily dose of opioids went way down.
Additional Support Provided By:
